SCHEMBL7987946

SCHEMBL7987946

Cc1ccc(Cn2cnc3nc(CN(C)C(=O)OC(C)(C)C)[nH]c(=O)c32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
CACNA1G O43497 1/20 0.39
CACNA1B Q00975 1/20 0.39
CACNA1C Q13936 1/20 0.39
KMT2A Q03164 1/20 0.38
CCNE2 O96020 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
HTR2C P28335 1/20 0.36
SLC6A4 P31645 1/20 0.36
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
LMNA P02545 2/20 0.34
BRD4 O60885 1/20 0.34
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974303 0.92 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1CACNA1GCACNA1B
SCHEMBL7992290 0.92 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1CACNA1GCACNA1B
SCHEMBL7985463 0.92 HPGD (0.52) HPGDSMN1; SMN2ALDH1A1CACNA1GCACNA1B
SCHEMBL7988125 0.87 HPGD (0.43) HPGDSMN1; SMN2ALDH1A1CACNA1GCACNA1B
SCHEMBL7987945 0.85 CACNA1G (0.39) HPGDSMN1; SMN2CACNA1GCACNA1BCACNA1C
SCHEMBL7988933 0.84 GAA (0.44) HPGDSMN1; SMN2ALDH1A1CACNA1GCACNA1B
SCHEMBL7975231 0.84 CACNA1G (0.40) HPGDSMN1; SMN2ALDH1A1CACNA1GCACNA1B
SCHEMBL7991611 0.83 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1CACNA1GCACNA1B
SCHEMBL7988916 0.83 HPGD (0.50) HPGDSMN1; SMN2ALDH1A1KMT2ACCNE2
SCHEMBL7987944 0.82 HTR2C (0.38) HPGDSMN1; SMN2CACNA1GCACNA1BCACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed